GNI Group Ltd. (TYO:2160)
2,619.00
+13.00 (0.50%)
Sep 11, 2025, 11:30 AM JST
GNI Group Revenue
GNI Group had revenue of 6.93B JPY in the quarter ending June 30, 2025, with 19.82% growth. This brings the company's revenue in the last twelve months to 24.13B, up 2.04% year-over-year. In the year 2024, GNI Group had annual revenue of 23.61B, down -9.22%.
Revenue (ttm)
24.13B
Revenue Growth
+2.04%
P/S Ratio
6.00
Revenue / Employee
27.83M
Employees
867
Market Cap
144.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23.61B | -2.40B | -9.22% |
Dec 31, 2023 | 26.01B | 8.59B | 49.33% |
Dec 31, 2022 | 17.42B | 4.73B | 37.26% |
Dec 31, 2021 | 12.69B | 2.92B | 29.85% |
Dec 31, 2020 | 9.77B | 2.33B | 31.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
Takeda Pharmaceutical Company | 4,480.25B |
HOYA Corporation | 876.09B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |